NFL to restrict unvaccinated coaches, staff from working with players
Team Biden halts J&J vaccine — and a return to normal
Biden: ‘I told y’all,’ we’ve got plenty of vaccine supply without J&J
J&J blood clots: What to know about the potentially dangerous condition
The CDC is examining the case of a woman who died after getting the Johnson & Johnson COVID-19 vaccine, a report said Tuesday.
The 45-year-old woman from Virginia had gotten the shot early last month, then went to the hospital two weeks later, on March 17, with a severe headache and bleeding on the brain, the Virginia-Pilot said, citing data from a federally run Web site that monitors adverse vaccine reactions.
The victim was intubated and died the next day, according to the FDA and CDC’s Vaccine Adverse Event Reporting System, the outlet said.
Both agencies on Tuesday announced they were recommending the J&J vaccine be at least temporarily yanked from use amid concerns over potentially deadly blood clotting.
Six women in the US between the ages of 18 and 48 developed clots after getting the immunization, with one dying and another in critical condition, the feds said.
In response, the White House said federally run vaccine centers would not be administering the shots for now, and states, cities and pharmacies soon followed suit.
Virginia health officials acknowledged in a statement later Tuesday that “the U.S. Centers for Disease Control & Prevention (CDC) confirmed to the Virginia Department of Health (VDH) that it is examining the March death of a Virginia woman as part of its investigation into possible adverse side effects from the Johnson & Johnson COVID-19 vaccine.
“The Virginia death was reported to the CDC’s Vaccine Adverse Event Reporting System (VAERS),” the state said.
Share this article:
Source: Read Full Article